Icosavax, Inc.

NasdaqGS:ICVX Voorraadrapport

Marktkapitalisatie: US$777.8m

Icosavax Toekomstige groei

Future criteriumcontroles 0/6

Icosavax is forecast to grow earnings and revenue by 20.9% and 64.5% per annum respectively while EPS is expected to grow by 27.1% per annum.

Belangrijke informatie

20.9%

Groei van de winst

27.1%

Groei van de winst per aandeel

Biotechs winstgroei27.1%
Inkomstengroei64.5%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt11 Jan 2024

Recente toekomstige groei-updates

Recent updates

We Think Icosavax (NASDAQ:ICVX) Can Afford To Drive Business Growth

Jul 04
We Think Icosavax (NASDAQ:ICVX) Can Afford To Drive Business Growth

Will Icosavax (NASDAQ:ICVX) Spend Its Cash Wisely?

Mar 10
Will Icosavax (NASDAQ:ICVX) Spend Its Cash Wisely?

Is Icosavax (NASDAQ:ICVX) In A Good Position To Invest In Growth?

Oct 18
Is Icosavax (NASDAQ:ICVX) In A Good Position To Invest In Growth?

Icosavax GAAP EPS of -$0.57

Aug 15

Icosavax to pursue COVID bivalent vaccine in 2023 as biotech highlights near-term milestones

Jul 28

Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation

Jun 22
Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation

Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation

Mar 24
Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation

We're Hopeful That Icosavax (NASDAQ:ICVX) Will Use Its Cash Wisely

Oct 29
We're Hopeful That Icosavax (NASDAQ:ICVX) Will Use Its Cash Wisely

Winst- en omzetgroeiprognoses

NasdaqGS:ICVX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202649-123-112134
12/31/20251-144-126-1305
12/31/2024N/A-115-112-1155
12/31/2023N/A-102-87-905
9/30/2023N/A-97-76-71N/A
6/30/2023N/A-97-79-70N/A
3/31/2023N/A-93-77-66N/A
12/31/20221-92-73-62N/A
9/30/20223-86-72-63N/A
6/30/20224-99-60-55N/A
3/31/20226-85-54-52N/A
12/31/20218-67-40-39N/A
9/30/20217-53-30-29N/A
6/30/20216-25-23-22N/A
3/31/20214-21-15-15N/A
12/31/20202-19-14-14N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: ICVX is forecast to remain unprofitable over the next 3 years.

Winst versus markt: ICVX is forecast to remain unprofitable over the next 3 years.

Hoge groeiwinsten: ICVX is forecast to remain unprofitable over the next 3 years.

Omzet versus markt: ICVX is forecast to have no revenue next year.

Hoge groei-inkomsten: ICVX is forecast to have no revenue next year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if ICVX's Return on Equity is forecast to be high in 3 years time


Ontdek groeibedrijven